<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="rss.xsl" ?>
<rss version="2.0">
	<channel>
		<title>Umanpharma - Nouvelles</title>
		<description>www.umanpharma.com</description>
		<link>http://www.umanpharma.com/news.html</link>
		
		<item>
			<title>Antares Pharma and Uman Pharma enter collaboration for VIBEX <sup>TM</sup> MTX</title>
			<description><p>Under the terms of the agreement, Antares and Uman will invest jointly to develop and commercialize VIBEX<sup>TM</sup> MTX, Antares' novel pressure-assisted injection device, containing methotrexate for rheumatoid arthritis and related autoimmune conditions in the US and Canada.</p></description>
			<guid>http://www.umanpharma.com/4-news-.html</guid>
		</item>				
		
		<item>
			<title>Uman Pharma gets approval by Health Canada</title>
			<description>Uman Pharma is proud to announce the receipt of the Establishment Licence from Health Canada for the production and packaging of sterile and solid oral dosage pharmaceutical products.</description>
			<guid>http://www.umanpharma.com/3-news-.html</guid>
		</item>				
		
		<item>
			<title>EPIRUBICIN</title>
			<description>Uman Pharma is offering the newly generic EPIRUBICIN drug in Canada.</description>
			<guid>http://www.umanpharma.com/1-news-.html</guid>
		</item>				
		
		<item>
			<title>Bristol Myers-Squibb facility acquisition</title>
			<description>Uman Pharma is proud to announce the acquisition of the Bristol Myers-Squibb facility in Candiac (Canada).</description>
			<guid>http://www.umanpharma.com/2-news-.html</guid>
		</item>				
		
	</channel>
</rss> 